Sterling Investment Counsel’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.35M Sell
5,704
-5,662
-50% -$1.18M 0.32% 58
2026
Q1
$2.4M Buy
11,366
+2
+0% +$431 0.67% 23
2025
Q4
$2.34M Hold
11,364
0.67% 25
2025
Q3
$1.78M Hold
11,364
0.57% 34
2025
Q2
$1.91M Sell
11,364
-1,000
-8% -$148K 1.12% 17
2025
Q1
$1.7M Sell
12,364
-700
-5% -$89.2K 0.58% 33
2024
Q4
$1.55M Hold
13,064
1.02% 19
2024
Q3
$1.44M Hold
13,064
0.51% 38
2024
Q2
$1.28M Hold
13,064
0.51% 37
2024
Q1
$1.46M Buy
13,064
+42
+0.3% +$4.53K 0.68% 32
2023
Q4
$1.31M Hold
13,022
0.67% 30
2023
Q3
$1.13M Hold
13,022
0.65% 29
2023
Q2
$1.23M Hold
13,022
0.66% 25
2023
Q1
$983K Hold
13,022
0.58% 28
2022
Q4
$1M Buy
+13,022
New +$989K 0.62% 32

Other funds holding CAH

Sterling Investment Counsel's CAH Position: Q2 2026 in Review

Sterling Investment Counsel reduced its Cardinal Health (CAH) stake by 50% in Q2 2026, selling an estimated $1.18M and leaving 5,704 shares worth $1.35M. The position accounts for 0.32% of the portfolio, ranked #58.

Sterling Investment Counsel first reported a position in CAH in Q4 2022 and has held it in 15 quarters since. The position peaked at $2.4M in Q1 2026. 617 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Sterling Investment Counsel held 5,704 shares of Cardinal Health worth $1.35M as of Q2 2026.
  • Sterling Investment Counsel sold 5,662 Cardinal Health shares in Q2 2026, an estimated $1.18M.
  • Cardinal Health made up 0.32% of Sterling Investment Counsel's portfolio in Q2 2026, its #58 holding.
  • Sterling Investment Counsel first reported a position in Cardinal Health in Q4 2022 and has held it in 15 quarters since.
  • Sterling Investment Counsel's Cardinal Health position peaked at $2.4M in Q1 2026.
  • 617 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Sterling Investment Counsel's 13F filing for Q2 2026, filed 20 Jul 2026.